Dishman Carbogen AmicsNSE:DCAL -2.41%71 Gross Margin % is 84.15% as of Mar. 2026, which is 8% above its 10-year median of 77.98. GuruFocus rates NSE:DCAL with a GF Score™ of 71/100 and a GF Value™ of ₹236.12 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 735 Biotechnology companies, Dishman Carbogen Amics ranks better than 78.78% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Dishman Carbogen Amics had a gross margin of 84.15% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Dishman Carbogen Amics Gross Margin % Related Terms
Dishman Carbogen Amics Gross Margin % Historical Data
* Premium members only.
The historical data trend for Dishman Carbogen Amics's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:DCAL vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Dishman Carbogen Amics's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dishman Carbogen Amics Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Dishman Carbogen Amics's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Dishman Carbogen Amics's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Dishman Carbogen Amics (NSE:DCAL) has a Gross Margin % of 84.15% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Dishman Carbogen Amics and its competitors. This is near median its historical median of 77.98. Over the past decade, Dishman Carbogen Amics' Gross Margin % has ranged from 74.42 to 86.06. According to the industry distribution chart, Dishman Carbogen Amics ranks #156 out of 735 companies in the Biotechnology industry, placing it in the top 21.2%.
Is Dishman Carbogen Amics' Gross Margin % too high?
Dishman Carbogen Amics' current Gross Margin % of 84.15% is near median its 10-year median of 77.98. Over the past 10 years, this metric has ranged from a low of 74.42 to a high of 86.06. The Biotechnology industry median Gross Margin % is 60.90. Dishman Carbogen Amics' value of 84.15% is 38.2% above this industry median. Based on the distribution chart, Dishman Carbogen Amics ranks #156 out of 735 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Dishman Carbogen Amics has a GF Score™ of 71/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dishman Carbogen Amics' Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Dishman Carbogen Amics ranks #156 out of 735 companies for Gross Margin %. This places Dishman Carbogen Amics in the top 21% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 60.90. Dishman Carbogen Amics' value of 84.15% is 38.2% above this benchmark. Historically, Dishman Carbogen Amics' own Gross Margin % has ranged from 74.42 to 86.06 over the past decade. While the company's 10-year median is 77.98 vs. the industry median of 60.90, Dishman Carbogen Amics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dishman Carbogen Amics's current Gross Margin % of 84.15% is 38.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Dishman Carbogen Amics and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dishman Carbogen Amics's current Gross Margin % is 84.15%, which is near median its own 10-year median of 77.98. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dishman Carbogen Amics stock overvalued right now?
Based on GuruFocus' analysis, Dishman Carbogen Amics (NSE:DCAL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹236.12, compared to a current price of ₹170.02 — trading 28% below its estimated fair value. The current Gross Margin % is 84.15%, which is near median its 10-year median of 77.98 and 38.2% above the Biotechnology industry median of 60.90. Dishman Carbogen Amics' overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Dishman Carbogen Amics (NSE:DCAL), the current Gross Margin % is 84.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dishman Carbogen Amics (NSE:DCAL) Overvalued in 2026?
Based on GuruFocus' analysis, Dishman Carbogen Amics stock appears to be undervalued.
The current stock price of ₹170.02 is trading 28% below its estimated GF Value™ of ₹236.12.
GuruFocus considers Dishman Carbogen Amics to be Modestly Undervalued.
Key valuation signals for NSE:DCAL:
Gross Margin %: 84.15% (near median its 10-year median of 77.98)
GF Value™: ₹236.12 vs. price of ₹170.02 (28% below fair value)
Industry Position: 38.2% above the Biotechnology median (#156 of 735)
No single metric tells the full story. See the NSE:DCAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dishman Carbogen Amics Ltd is a biotechnology company that provides contract research and manufacturing services for pharmaceutical companies. It manufactures bulk drugs, specialty chemicals, and outsourced goods. Additionally, the company produces vitamins, such as vitamin D2 and vitamin D3, reagents, antiseptics and disinfectants, transfer catalysts, personal-care ingredients, pharma intermediates, and ammonium and phosphonium high-purity solid Quats. The business generates the vast majority of its revenue in India.
71GF Score
Get the complete analysis for NSE:DCAL
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:DCAL has been successfully added to your 
